期刊文献+

血清抗环瓜氨酸肽抗体及类风湿因子联合检测在诊断类风湿关节炎中的应用价值 被引量:1

下载PDF
导出
摘要 目的:探讨血清抗环瓜氨酸肽抗体及类风湿因子联合检测在诊断类风湿关节炎中的应用价值。方法:选取2015年2月至2017年2月期间荣县中医医院收治的80例类风湿关节炎患者作为观察组,另选取同期在该院进行体检的80例健康体检者作为对照组。对这两组人员均进行血清抗环瓜氨酸肽抗体检测和血清类风湿因子检测。然后比较其血清抗环瓜氨酸肽抗体、类风湿因子的水平,并比较用血清抗环瓜氨酸肽抗体检测、血清类风湿因子检测和血清抗环瓜氨酸肽抗体及类风湿因子联合检测诊断类风湿关节炎的敏感度和特异度。结果:观察组患者血清抗环瓜氨酸肽抗体、类风湿因子的水平均高于对照组体检者,P<0.05。与用血清类风湿因子检测或血清抗环瓜氨酸肽抗体检测相比,用血清抗环瓜氨酸肽抗体及类风湿因子联合检测诊断类风湿关节炎的敏感度和特异度均更高,P<0.05。结论:血清抗环瓜氨酸肽抗体及类风湿因子联合检测在诊断类风湿关节炎中的应用价值较高。
作者 李坪友
出处 《当代医药论丛》 2018年第12期188-189,共2页
  • 相关文献

参考文献2

二级参考文献17

  • 1陈晓玲,潘莎琳,高志芬.CCP抗体和RF在类风湿性关节炎诊断中的应用[J].四川医学,2006,27(7):690-691. 被引量:7
  • 2Landew R. The benefits of early treatment in rheumatoid arthritis:confounding by indication, and the issue of tim- ing[J]. Arthritis ~ Rheumatism,2003,48(1) : 1-5.
  • 3Arnett FC, Edworthy SM, Blocn DA, et al. The American Rheumatism Association 1987 revised criteria {or the clas- sification of rheumatoid arthritis[J]. Arthritis ~ Rheuma- tism,2010,31(3),315-324.
  • 4Kroot EJ,de Jong BA,van Leeuwen MA,et al. The prog- nostic value of anticyclic citrullinated peptide antibody in patients with recentonset rheumatoid arthritis[-J3. Arthri- tis ~ Rheumatism,2000,43(8) : 1831-1835.
  • 5Combe B, I.andew R, Lukas C, et al. EULAR recommen- dations for the management of early arthritis:report of a task force of the European Standing Committee for Inter national Clinical Studies Including Therapeutics (ES- CISIT) [J]. Annals of the Rheumatic Diseases, 2007,66 (1) :34-45.
  • 6Schellekens GA, de Jong BA, Van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determi- nants recognized by rheumatoid arthritis-specific autoanti- bodies[J]. Journal of Clinical Investigation, 1998, 101 (10) :273-275.
  • 7Cader MZ, Filer AD, Buckley CD, et al. The relationship between the presence of anti-cyclic citrulliuated peptide antibodies and clinical phe- notype in very early rheumatoid arthritis[ J]. BMC Musculoskelet Dis- ord,2010, ( 11 ) :187.
  • 8Goeldner I, Skare TL, de Messias Reason IT, et al. Anti-cyclic citrulli- nated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil [ J ]. Rheumatology ( Oxford ), 2010,49 (8) :1590-1593.
  • 9Huo AP, Lin KC, Chou CT. Predictive and prognostic value of antinu- clear antibodies and rheumatoid factor in primary Sjogren ~s syndrome [ J]. Int J Rheum Dis,2010,13 ( 1 ) :39-47.
  • 10Orge E, Cefle A, Yazici A, et al. The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection [ J ]. Rheumatol Int, 2010, 30 ( 4 ) : 485-488.

共引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部